Tonghua Dongbao Pharmaceutical Co., Ltd.
600867Pharmaceuticals
CN¥7.78+2.64%As of Oct 29vs prior close
- Market cap
- $2.3B
- P/E (TTM)
- 11.4×
- P/E (FY1)
- 24.1×
- From 52W high
- −25.83%
- EPS (LTM)
- CN¥0.66
- Revenue (LTM)
- CN¥3.1B
- Net margin
- 41.88%
Nomior Score
34
Steady ProfileBottom 20% of the scored universe
Growth49
Quality50
Value36
Momentum16
Resilience57
Growth
+1.99%revenue a year over 3 fiscal years
YE22 CN¥2.8BLTM CN¥3.1B
Connections
Revenue to profitYE25
41% of revenue became net profit, up 43 pts on a year.